RB1 and breast cancer: RBsig, a gene expression signature of Rb loss-of-function, has been validated in identifying between palbociclib-sensitive and resistant BC cell lines (21), and has been associated with sensitivity to abemaciclib monotherapy in tumors derived from the neoMONARCH study (NCT02441948) (22).